| |
|
|
MEDIA STATEMENT
28th September 2006
Further comment
From the International Ibuprofen Foundation
Following EMEA press release on the review of NSAIDs
It should be emphasised that the review is exclusively confined to prescription
use of NSAIDs including Ibuprofen ie high doses and long duration and
is not in any way associated with over-the-counter (OTC) low doses for
minor ailments by the general public.
The patients in this study were taking high doses of at least 800mg, 3
times a day; this is twice the recommended maximum dose for over-the-counter
use. Experts have stressed the health fears only apply to high doses of
NSAIDs prescribed by GPs and not the Ibuprofen and other pills bought
over-the-counter.
Ibuprofen has been available to the public directly for many years OTC
and is known to be effective and well tolerated. Prescription use is generally
for longer periods, in higher doses and is known to have a different safety
profile from self-medication usage at low doses. Self medication ibuprofen
is a very safe and effective medicine, and research shows that Ibuprofen
at non-prescription doses is not associated with increased risk of heart
attack. 1 2 3
When the European Medicines Agency held a similar review in October 2005
their conclusions were, “There are no new concerns about the safety
of NSAIDs such as ibuprofen”. This decision was reached having reviewed
a wide range of evidence.
Ends
Addendum
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA)
has stated ‘Ibuprofen has an excellent safety record’
1 Patel NT, Goldberg KC Arch Intern Med 2004; 164:852-856
2 Kurth T, et al. Curculation 2003;108 :1191-1195
3 Hudson M et al, Anti-inflammatory drugs are associated with a decreased
risk of recurrent acute myocardial infarction in patients on aspirin.
American College of Rheumatology Annual Scientific Meeting 2003
Further comment from the IIF:
It is important that the media in reporting scientific data concerning
ibuprofen consistently distinguish between prescription use of ibuprofen
dose forms designed for use under strict medical supervision and less
potent dose forms available to the general public over-the-counter.
There has been consistent confusion in media interpretation of data which
has lead to inappropriate comment and concern for the public who may be
less able than journalists to distinguish between OTC use and prescription
use.
It is important therefore that the public should be provided with unsensational
and objective media reports.
Contact
us
For more information.
| |